BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34028430)

  • 1. Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research.
    Xu X; Shang L; Wang P; Zhou J; Ouyang X; Zheng M; Mao B; Zhang L; Chen B; Wang J; Chen J; Qian W; Guo S; Huang Y; Li QX
    J Vis Exp; 2021 May; (171):. PubMed ID: 34028430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology.
    Xu X; Kumari R; Zhou J; Chen J; Mao B; Wang J; Zheng M; Tu X; An X; Chen X; Zhang L; Tian X; Wang H; Dong X; Bao Z; Guo S; Ouyang X; Shang L; Wang F; Yan X; Zhang R; Vries RGJ; Clevers H; Li QX
    PLoS One; 2023; 18(1):e0279821. PubMed ID: 36602988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and Development.
    Kumari R; Xu X; Li HQ
    Curr Protoc; 2022 Jul; 2(7):e431. PubMed ID: 35789132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
    Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
    Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.
    Takada K; Aizawa Y; Sano D; Okuda R; Sekine K; Ueno Y; Yamanaka S; Aoyama J; Sato K; Kuwahara T; Hatano T; Takahashi H; Arai Y; Nishimura G; Taniguchi H; Oridate N
    Int J Cancer; 2021 Jan; 148(1):193-202. PubMed ID: 32984947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting.
    Aizawa Y; Takada K; Aoyama J; Sano D; Yamanaka S; Seki M; Kuze Y; Ramilowski JA; Okuda R; Ueno Y; Nojima Y; Inayama Y; Hatakeyama H; Hatano T; Takahashi H; Nishimura G; Fujii S; Suzuki Y; Taniguchi H; Oridate N
    Cell Oncol (Dordr); 2023 Apr; 46(2):409-421. PubMed ID: 36538240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts.
    Thomas PB; Alinezhad S; Joshi A; Sweeney K; Tse BWC; Tevz G; McPherson S; Nelson CC; Williams ED; Vela I
    Curr Oncol; 2023 Oct; 30(11):9437-9447. PubMed ID: 37999103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor.
    Okazawa Y; Mizukoshi K; Koyama Y; Okubo S; Komiyama H; Kojima Y; Goto M; Habu S; Hino O; Sakamoto K; Orimo A
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29985333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer.
    Fong ELS; Toh TB; Lin QXX; Liu Z; Hooi L; Mohd Abdul Rashid MB; Benoukraf T; Chow EK; Huynh TH; Yu H
    Biomaterials; 2018 Mar; 159():229-240. PubMed ID: 29353739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived xenografts and organoids model therapy response in prostate cancer.
    Karkampouna S; La Manna F; Benjak A; Kiener M; De Menna M; Zoni E; Grosjean J; Klima I; Garofoli A; Bolis M; Vallerga A; Theurillat JP; De Filippo MR; Genitsch V; Keller D; Booij TH; Stirnimann CU; Eng K; Sboner A; Ng CKY; Piscuoglio S; Gray PC; Spahn M; Rubin MA; Thalmann GN; Kruithof-de Julio M
    Nat Commun; 2021 Feb; 12(1):1117. PubMed ID: 33602919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
    Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS
    Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
    Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A
    United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient-Derived Xenografts.
    Mohamed Suhaimi NA; Phyo WM; Yap HY; Choy SHY; Wei X; Choudhury Y; Tan WJ; Tan LAPY; Foo RSY; Tan SHS; Tiang Z; Wong CF; Koh PK; Tan MH
    Mol Cancer Ther; 2017 Sep; 16(9):2035-2044. PubMed ID: 28533437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
    Owonikoko TK; Zhang G; Kim HS; Stinson RM; Bechara R; Zhang C; Chen Z; Saba NF; Pakkala S; Pillai R; Deng X; Sun SY; Rossi MR; Sica GL; Ramalingam SS; Khuri FR
    J Transl Med; 2016 May; 14(1):111. PubMed ID: 27142472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening.
    Beshiri ML; Tice CM; Tran C; Nguyen HM; Sowalsky AG; Agarwal S; Jansson KH; Yang Q; McGowen KM; Yin J; Alilin AN; Karzai FH; Dahut WL; Corey E; Kelly K
    Clin Cancer Res; 2018 Sep; 24(17):4332-4345. PubMed ID: 29748182
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascularized tissue on mesh-assisted platform (VT-MAP): a novel approach for diverse organoid size culture and tailored cancer drug response analysis.
    Lee J; Jung S; Hong HK; Jo H; Rhee S; Jeong YL; Ko J; Cho YB; Jeon NL
    Lab Chip; 2024 Apr; 24(8):2208-2223. PubMed ID: 38533822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
    Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
    Kawaguchi T; Foster BA; Young J; Takabe K
    J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.